½Å°æÁúȯ ½ÃÀåÁ¶»çº¸°í¼­

½Å°æÁúȯ(Neurodegenerative Disease) Ä«Å×°í¸®¿¡¼­´Â ½Å°æº¯¼º Áúȯ(´Ù¹ß¼º°æÈ­Áõ(MS), Ä¡¸Å, ¾ËÃ÷ÇÏÀ̸Ӻ´, °£Áú µî)À» Á¶»ç ´ë»óÀ¸·Î ÇÑ º¸°í¼­¸¦ ¼Ò°³ÇØ µå¸®°í ÀÖ½À´Ï´Ù. ÁßÃ߽Űæ°è ¾à¹° ÆÄÀÌÇÁ¶óÀÎ ¹× ¿¬±¸°³¹ß °ü·Ã °úÁ¦, ½ÃÀåÀÇ °¡´É¼º µî¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇÑ º¸°í¼­µµ Çѵ¥ ¸ð¾Ò½À´Ï´Ù.

1 - 25 (Àüü: 599°Ç)
ARMET À¯»ç ´Ü¹éÁú 1 ½ÃÀå º¸°í¼­ : µ¿Çâ, ¿¹Ãø, °æÀï ºÐ¼®(-2031³â)
ARMET-like Protein 1 Market Report: Trends, Forecast and Competitive Analysis to 2031
¹ßÇà 2025³â 09¿ù
°¡°Ý US $ 3,850 £Ü 5,537,000 (ºÎ°¡¼¼ º°µµ)
¾ËÃ÷ÇÏÀ̸Ӻ´ ¹ÙÀÌ¿À¸¶Ä¿ ±â¹Ý Áø´Ü ½ÃÀå - ¼¼°è ¹× Áö¿ªº° ºÐ¼®, Áö¿ªº° - ºÐ¼® ¹× ¿¹Ãø(2025-2035³â)
Alzheimer Biomarker Based Diagnostic Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035
¹ßÇà 2025³â 09¿ù
°¡°Ý US $ 4,900 £Ü 7,047,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ½Å°æº´Áõ¼º ÅëÁõ ½ÃÀå º¸°í¼­(2025³â)
Neuropathic Pain Global Market Report 2025
¹ßÇà 2025³â 09¿ù
°¡°Ý US $ 4,490 £Ü 6,457,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ½Å°æ¼¶À¯Á¾Áõ Ä¡·á ½ÃÀå º¸°í¼­(2025³â)
Neurofibromatosis Treatment Global Market Report 2025
¹ßÇà 2025³â 09¿ù
°¡°Ý US $ 4,490 £Ü 6,457,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ½Å°æÅë Ä¡·á ½ÃÀå º¸°í¼­(2025³â)
Neuralgia Treatment Global Market Report 2025
¹ßÇà 2025³â 09¿ù
°¡°Ý US $ 4,490 £Ü 6,457,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ±Þ¼º ô¼ö ¼Õ»ó ½ÃÀå º¸°í¼­(2025³â)
Acute Spinal Cord Injury Global Market Report 2025
¹ßÇà 2025³â 09¿ù
°¡°Ý US $ 4,490 £Ü 6,457,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ÁßÁõ±Ù¹«·ÂÁõ Ä¡·á ½ÃÀå º¸°í¼­(2025³â)
Myasthenia Gravis Treatment Global Market Report 2025
¹ßÇà 2025³â 09¿ù
°¡°Ý US $ 4,490 £Ü 6,457,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ³úÁøÅÁ ½ÃÀå º¸°í¼­(2025³â)
Concussion Global Market Report 2025
¹ßÇà 2025³â 09¿ù
°¡°Ý US $ 4,490 £Ü 6,457,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ È­Çпä¹ý À¯¹ß¼º ¸»ÃʽŰ溴Áõ Ä¡·á ½ÃÀå º¸°í¼­(2025³â)
Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Report 2025
¹ßÇà 2025³â 09¿ù
°¡°Ý US $ 4,490 £Ü 6,457,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ³ú¼º ¸¶ºñ Ä¡·á ½ÃÀå º¸°í¼­(2025³â)
Cerebral Palsy Treatment Global Market Report 2025
¹ßÇà 2025³â 09¿ù
°¡°Ý US $ 4,490 £Ü 6,457,000 (ºÎ°¡¼¼ º°µµ)
±ÙÀ§Ã༺ Ãø»ö °æÈ­Áõ(ALS) ½ÃÀå ºÐ¼®°ú ¿¹Ãø : À¯Çü, Á¦Ç°, ¼­ºñ½º, ±â¼ú, ÄÄÆ÷³ÍÆ®, ¿ëµµ, µð¹ÙÀ̽º, ÇÁ·Î¼¼½º, ÃÖÁ¾ »ç¿ëÀÚ
Amyotrophic Lateral Sclerosis Market Analysis and Forecast to 2034: Type, Product, Services, Technology, Component, Application, Device, Process, End User
¹ßÇà 2025³â 09¿ù
°¡°Ý US $ 4,750 £Ü 6,831,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ³úÁ¹Áß ½ÃÀå º¸°í¼­(2025³â)
Stroke Global Market Report 2025
¹ßÇà 2025³â 09¿ù
°¡°Ý US $ 4,490 £Ü 6,457,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ³úÀüÁõ Áö¼ÓÁõ ½ÃÀå º¸°í¼­(2025³â)
Status Epilepticus Global Market Report 2025
¹ßÇà 2025³â 09¿ù
°¡°Ý US $ 4,490 £Ü 6,457,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ µµ³×ÆäÁú(Donepezil) ½ÃÀå º¸°í¼­(2025³â)
Donepezil Global Market Report 2025
¹ßÇà 2025³â 09¿ù
°¡°Ý US $ 4,490 £Ü 6,457,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Äݸ°¿¡½ºÅ×¶ó¾ÆÁ¦(ChE) ¾ïÁ¦Á¦ ½ÃÀå º¸°í¼­(2025³â)
Cholinesterase (ChE) Inhibitors Global Market Report 2025
¹ßÇà 2025³â 09¿ù
°¡°Ý US $ 4,490 £Ü 6,457,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ µà¼¾ ±ÙÀÌ¿µ¾çÁõ ½ÃÀå º¸°í¼­(2025³â)
Duchenne Muscular Dystrophy Global Market Report 2025
¹ßÇà 2025³â 09¿ù
°¡°Ý US $ 4,490 £Ü 6,457,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ±¸Åä ¹æÁöÁ¦ ¹× ¸Þ½º²¨¿ò ¹æÁöÁ¦ ½ÃÀå º¸°í¼­(2025³â)
Antiemetics And Antinauseants Global Market Report 2025
¹ßÇà 2025³â 09¿ù
°¡°Ý US $ 4,490 £Ü 6,457,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ µå¶óº£ ÁõÈıº ½ÃÀå ¿¹Ãø(-2032³â) : ¾à¹° À¯Çü, Ä¡·á À¯Çü, ¹ßÀÛ À¯Çü, À¯Åë ä³Î, Áö¿ªº° ºÐ¼®
Dravet Syndrome Market Forecasts to 2032 - Global Analysis By Drug Type, Treatment Type, Seizure Type, Distribution Channel and By Geography
¹ßÇà 2025³â 09¿ù
°¡°Ý US $ 4,150 £Ü 5,968,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ½Å°æÅë Ä¡·á ½ÃÀå : Ä¡·áº°, ÃÖÁ¾ ¿ëµµº°, ±¹°¡º°, Áö¿ªº° »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2025-2032³â)
Neuralgia Treatment Market, By Treatment, By End Use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
¹ßÇà 2025³â 09¿ù
°¡°Ý US $ 3,250 £Ü 4,674,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ÀüµÎÃøµÎ¿± Ä¡¸Å ½ÃÀå : ¾àÁ¦ Ŭ·¡½ºº°, ÀûÀÀ Áúȯº°, À¯Åë ä³Îº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¿¹Ãø(2025-2032³â)
Frontotemporal Dementia Market, By Drug Class, By Disease Indication, By Distribution Channel, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
¹ßÇà 2025³â 09¿ù
°¡°Ý US $ 3,250 £Ü 4,674,000 (ºÎ°¡¼¼ º°µµ)
B»çÀÌÆ® ¾Æ¹Ð·ÎÀ̵å Àü±¸Ã¼ ´Ü¹éÁú Àý´Ü È¿¼Ò 1(BACE1) ¾ïÁ¦Á¦ ½ÃÀå ±Ô¸ð, Ç¥Àû Áý´Ü, °æÀï ±¸µµ, ½ÃÀå ¿¹Ãø(2034³â)
B-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast - 2034
¹ßÇà 2025³â 09¿ù
°¡°Ý US $ 7,950 £Ü 11,434,000 (ºÎ°¡¼¼ º°µµ)
Äݸ°¿¡½ºÅ×¶ó¾ÆÁ¦(ChE) ¾ïÁ¦Á¦ ½ÃÀå ±Ô¸ð, Ç¥Àû Áý´Ü, °æÀï ±¸µµ, ½ÃÀå ¿¹Ãø(2034³â)
Cholinesterase (ChE) Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast - 2034
¹ßÇà 2025³â 09¿ù
°¡°Ý US $ 7,950 £Ü 11,434,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ·ÎÀڳ½ÃÁÖ¸¿(Rystiggo) ½ÃÀå : »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø - ÀûÀÀÁõº°, À¯Åë ä³Îº°, Áö¿ªº°, °æÀﺰ(2020-2030³â)
Rozanolixizumab Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Indication (Generalized Myasthenia Gravis, Others), By Distribution Channel, By Region and Competition, 2020-2030F
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 4,500 £Ü 6,472,000 (ºÎ°¡¼¼ º°µµ)
¾ËÃ÷ÇÏÀ̸Ӻ´ Áø´Ü¿ë Ç÷¾× ±â¹Ý ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : À¯Çüº°, ±â¼úº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2033³â)
Blood-based Biomarker For Alzheimer's Disease Diagnostics Market Size, Share & Trends Analysis Report By Type, By Technology, By End-use, By Region, And Segment Forecasts, 2025 - 2033
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,950 £Ü 8,557,000 (ºÎ°¡¼¼ º°µµ)
´ç´¢º´¼º ¸»ÃʽŰ溴Áõ ½ÃÀå : Ä¡·á À¯Çüº°, Åõ¿© °æ·Îº°, ÃÖÁ¾»ç¿ëÀÚº°, À¯Åë ä³Îº°, ¿¬·ÉÃþº° - ¼¼°è ¿¹Ãø(2025-2030³â)
Diabetic Peripheral Neuropathy Market by Treatment Type, Route of Administration, End-User, Distribution Channel, Age Group - Global Forecast 2025-2030
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 3,939 £Ü 5,665,000 (ºÎ°¡¼¼ º°µµ)
(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.